Business
Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceutical...
About this update from Medexus Pharmaceuticals Inc.
[{"type":"text","content":"Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceToronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference from April 16 to 17, 2024.Event: 2024 Bloom Burton & Co. Healthcare Investor ConferenceDate: April 16-17, 2024Location: Toronto, OntarioMedexus Presentation: Wednesday, April 17 at 1:30 PM Eastern timeKen d'Entremont, Medexus's Chief Executive Officer, and Marcel Konrad, Medexus's Chief Financial Officer, will deliver a presentation on April 17, 2024 at 1:30 PM Eastern time and will be available for in-person one-on-one meetings throughout the conference.A live and recorded webcast of the Medexus presentation will be available on the Investors-News & Events section of Medexus's corporate website or at the following link:https://wsw.com/webcast/bloomburton9/mdp.to/3096792About MedexusMedexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus's current focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. For more information about Medexus and its product portfolio, please see the company's corporate website at www.medexus.com and its filings on SEDAR+ at www.sedarplus.ca.ContactsKen d'Entremont | CEO, Medexus PharmaceuticalsTel: 905-676-0003 | Email: [email protected] Konrad | CFO, Medexus PharmaceuticalsTel: 312-548-3139 | Email: [email protected] Rutherford | Adelaide CapitalTel: 480-625-5772 | Email: [email protected] statementsCertain statements made in this news release contain forward-looking information within the meaning of applicable securities laws, also known and/or referred to as \"forward looking information\" or \"forward-looking statements\". The words \"anticipates\", \"believes\", \"expects\", \"will\", \"plans\", \"potential\", and similar words, phrases, or expressions are often intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words, phrases, or expressions. Th...